Consonance Capital Management LP Silence Therapeutics PLC Transaction History

Consonance Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.99 - $19.5 $158,505 - $386,841	-19,838 Reduced 3.03%	634,270 $7.52 Million
Q1 2022 May 16, 2022	SELL	$16.5 - $23.89 $1.72 Million - $2.49 Million	-104,145 Reduced 13.73%	654,108 $12.4 Million
Q4 2021 Feb 14, 2022	BUY	$20.61 - $25.71 $11.9 Million - $14.9 Million	579,466 Added 324.11%	758,253 $18.1 Million
Q3 2021 Nov 15, 2021	SELL	$20.61 - $26.87 $895,195 - $1.17 Million	-43,435 Reduced 19.55%	178,787 $3.73 Million
Q1 2021 May 17, 2021	BUY	$21.8 - $28.01 $4.84 Million - $6.22 Million	222,222 New	222,222 $5.11 Million

28.1M

300

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $217M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.